Biomarker predicts effectiveness of brain cancer temozolomide treatment

Biomarker predicts effectiveness of brain cancer treatment – Researchers at the University of California, San Diego School of Medicine have identified a new biomarker that predicts whether glioblastoma – the most common form of primary brain cancer – will respond to chemotherapy.

Cyramza for stomach cancer approved in US

FDA approves Cyramza for stomach cancer – Cyramza (ramucirumab) is approved to treat patients with advanced stomach cancer or gastroesophageal junction adenocarcinoma, a form of cancer located in the region where the esophagus joins the stomach.

Crohn’s disease – accelerated step-care a best management practice

REACT clinical trial supports new approach of accelerated treatment for Crohn’s disease – The final results from an international clinical trial involving nearly 2,000 patients with Crohn’s disease support the use of a new management strategy referred to as accelerated step-care as a best practice for the care of active Crohn’s disease.

One dose of HPV vaccine similar to three dose regimen

Fewer Doses of HPV Vaccine Result in Immune Response Similar to Three-Dose Regimen – Two doses of a human papillomavirus (HPV) vaccine, trademarked as Cervarix, resulted in similar serum antibody levels against two of the most carcinogenic types of HPV (16 and 18), compared to a standard three dose regimen.

Botox Cosmetic approved to improve crow’s feet lines

US FDA approves Botox Cosmetic to improve the appearance of crow’s feet lines – A new use for Botox Cosmetic (onabotulinumtoxinA) for the temporary improvement in the appearance of moderate to severe lateral canthal lines, known as crow’s feet, in adults is approved in USA. Botox Cosmetic is the only FDA approved drug treatment option for lateral canthal lines.

Pazopanib better than sunitinib in advanced kidney cancer

Pazopanib shows better quality-of-life in advanced kidney cancer – Two oral targeted drugs — Pazopanib (Votrient) and sunitinib (Sutent) — approved for metastatic kidney cancer worked equally well, but one proved superior in tolerability, the safety profile and many measures of quality of life favored pazopanib.

Urine test can diagnose and predict kidney transplant rejection

Urine test can diagnose, predict kidney transplant rejection — NIH-funded study describes noninvasive alternative to kidney biopsy – Analysis of three biomarkers in the urine of kidney transplant recipients can diagnose — and even predict — transplant rejection, according to results from a clinical trial sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

Nanodiamonds may improve effectiveness of breast cancer treatment

UCLA researchers find nanodiamonds could improve effectiveness of breast cancer treatment – Recently, doctors have begun to categorize breast cancers into four main groups according to the genetic makeup of the cancer cells. Which category a cancer falls into generally determines the best method of treatment.

Sirturo – first drug to treat multi drug resistant tuberculosis

FDA approves first drug to treat multi-drug resistant tuberculosis – The U.S. Food and Drug Administration approved Sirturo (bedaquiline) as part of combination therapy to treat adults with multi-drug resistant pulmonary tuberculosis (TB) when other alternatives are not available.

Fulyzaq – first anti diarrheal drug for HIV AIDS patients

FDA approves first anti-diarrheal drug for HIV/AIDS patients — Fulyzaq is the second botanical drug approved by the agency – The U.S. Food and Drug Administration approved Fulyzaq (crofelemer) to relieve symptoms of diarrhea in HIV/AIDS patients taking antiretroviral therapy, a combination of medicines used to treat HIV infection.

Health Newstrack